Summary of What STERIS plc Does

Company Overview:
STERIS plc is a leading global provider focused on supporting patient care and infection prevention through innovative healthcare and life science products and services.

Core Business Operations:

• Products and Services Offered:

  • Consumable Products: Detergents, endoscopy accessories, barrier products, instruments, and tools.
  • Capital Equipment: Sterilizers, surgical tables, automated endoscope reprocessors, operating room infrastructure.
  • Services: Equipment installation, maintenance, upgrades, repairs, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing services.
  • Connectivity Solutions: Operating room integration and digital connection solutions.

• Global Segments Reported:

  • Healthcare Segment: Supplies to healthcare providers, focusing on sterile processing departments and procedural centers like operating rooms and endoscopy suites.
  • Applied Sterilization Technologies (AST) Segment: Supports medical device and pharmaceutical manufacturers with contract sterilization, laboratory testing, and sterilization equipment/control systems.
  • Life Sciences Segment: Focuses on biopharmaceutical and medical device manufacturing, especially aseptic manufacturing, offering capital equipment, consumables, maintenance, and specialty services.

• Business Focus & Market Drivers:

  • Primarily supplies healthcare, medical device, and pharmaceutical customers.
  • Growth driven by aging populations globally, increased demand for medical procedures (preventive screenings, endoscopies, colonoscopies), healthcare industry innovations, and a push for operational efficiency.

Customer & Revenue Details:

• Number of Employees: Approximately 18,000 employees globally during fiscal year 2025.
• Customer Base:
  • No single customer accounted for more than 10% of segment revenues in fiscal year 2025.
  • Customers include hospitals, healthcare providers, pharmaceutical companies, and medical device manufacturers worldwide.
• Revenue:
  • Total Revenue for FY 2025: $5.46 billion (up 6.2% from FY 2024).
  • Segment Revenue Breakdown (FY 2025):
    • Healthcare: About 71% (~$3.88 billion)
    • AST: About 19% (~$1.04 billion)
    • Life Sciences: About 10% (~$542 million)
  • Geographic Revenue:
    • U.S. accounts for the largest share (~$4 billion), with growth driven by service and consumable sales.
    • Ireland contributed approximately $107 million, a 29.8% increase over the previous year.
    • Other foreign regions contributed around $1.34 billion.

Financial Highlights:

• Gross Profit:

  • Total gross profit of approximately $2.40 billion in FY 2025, representing a gross margin of 44%.
  • Increases from FY 2024 due to better pricing, mix, productivity, and lower material costs.

• Income from Operations:

  • FY 2025: $866.6 million (up 3.7% from FY 2024).
  • Segment-wise:
    • Healthcare: ~$971 million
    • AST: ~$465 million
    • Life Sciences: ~$229 million
  • Overall operating margin around 15.8% (based on operating income / revenue).

• Profitability & Growth:

  • Revenue growth driven by volume increases and pricing strategies across segments.
  • Focus on innovation, quality, and operational efficiency.

Additional Company Details:

• Employees: About 18,000 worldwide.

• Customer Concentration: Less than 10% revenue from any single customer, ensuring broad customer diversification.

• Revenue (FY 2025): ~$5.46 billion.

• Net Income:

  • Operating income of $866.6 million with pretax income details not specified in exact dollar terms, but net income after taxes is implied to be significant given the profit margins.

• Business Strategy:

  • Growth through internal product/service development, capacity expansion, acquisitions, and strategic divestitures.
  • Focus on infection prevention, sterilization, and aseptic manufacturing solutions.
  • Committed to quality, regulatory compliance, environmental initiatives, and corporate responsibility.

In summary:
STERIS plc designs, manufactures, and provides equipment, consumables, and services to support infection control, sterilization, and procedural support worldwide. It caters mainly to hospitals, healthcare providers, pharmaceutical, and medical device industries, with a diversified global customer base, strong revenue growth, and around 18,000 employees.